Cargando…
Black raspberries in cancer clinical trials: Past, present and future
BACKGROUND: Black raspberries (BRB) inhibit a broad range of cancers in preclinical models, including in vivo models of oral, esophageal, colon, breast and skin cancer. Promising preclinical results have led to clinical evaluations in cancer patients or patients at increased risk for cancer developm...
Autores principales: | Kresty, Laura A., Mallery, Susan R., Stoner, Gary D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008867/ https://www.ncbi.nlm.nih.gov/pubmed/27594930 http://dx.doi.org/10.3233/JBR-160125 |
Ejemplares similares
-
A phase I pilot study evaluating the beneficial effects of black raspberries in patients with Barrett’s esophagus
por: Kresty, Laura A., et al.
Publicado: (2016) -
Herceptin clinical trials: past, present and future
por: Vogel, CL
Publicado: (2001) -
Black Raspberry-Derived Anthocyanins Demethylate Tumor Suppressor Genes Through the Inhibition of DNMT1 and DNMT3B in Colon Cancer Cells
por: Wang, Li-Shu, et al.
Publicado: (2013) -
A High-Throughput Metabolic Microarray Assay Reveals Antibacterial Effects of Black and Red Raspberries and Blackberries against Helicobacter pylori Infection
por: Goodman, Candace, et al.
Publicado: (2021) -
Chemopreventive Properties of Black Raspberries and Strawberries in Esophageal Cancer Review
por: Shi, Ni, et al.
Publicado: (2022)